Business and Technology News

Business, Life Sciences, and Technology News

While treatments for many health conditions have undergone reinvention in the past two decades, birth control options haven’t changed much. On Friday, San Diego-based Evofem Biosciences said it received FDA approval for a new kind of contraceptive: a non-hormonal vaginal gel intended for use directly before intercourse. The drug, a combination of lactic acid, citric […]

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won’t truly return to anything resembling a pre-pandemic normal without a COVID-19 vaccine. Moderna (NASDAQ: MRNA) moved one step closer to filling that need with the release of preliminary Phase […]

AMAG Pharmaceuticals wants out of the women’s health business—and now it’s halfway there. On Thursday the Waltham, MA-based biotech said it had found a buyer for prasterone (Intrarosa), a steroid designed to treat pain during intercourse associated with menopause, one of two commercialized drugs it has been shopping around. The buyer of the AMAG Pharma […]

The US Health and Human Services agency isn’t ready to go all in on “pull” incentives to encourage the development of new antibiotics, the agency indicated in response to a new Government Accountability Office report. “It is still unclear whether post-market financial incentives should necessarily be part of HHS’s forthcoming strategic framework to further incentivize […]

This was a disappointing week for at least two major drug makers. French firm Genfit reported a trial failure in an intensely competitive indication, and New York-based Bristol Myers Squibb encountered a delay when the FDA declined to review its experimental multiple myeloma treatment. Genfit (NASDAQ: GNFT) was developing a treatment for nonalcoholic steatohepatitis, or […]

It may seem like an unlikely link but the body’s response to arthritis may hold answers for better cancer drugs, says Luis Voloch, chief technology officer of startup Immunai. Immune cells respond to both conditions, but in different ways. Insights into the response for one disease could inform the treatment of the other, he says. […]

Section Page news and features from Crain's New York Business

To view the full story, click the title link.

To view the full story, click the title link.

The International Monetary Fund is warning banks against taking on excessive risks to offset the reduced profitability that results from low interest rates once economies begin to recover from the...

To view the full story, click the title link.

Customers keep popping into the New York City dry-cleaning shop where Rolando Matute works to say how happy they are to see it open again. He’s not so sure.“I don’t really feel safe,” he said on...

To view the full story, click the title link.

Lucky Lee is fortunate and knows it. Two months ago her 37-year-old business of supplying tomatoes to Danny Meyer, Jean-George Vongerichten and other star restaurateurs was in free fall. But...

To view the full story, click the title link.

Nonprofits, small landlords and mom-and-pop outfits—especially minority- and women-owned t from the state with the New York Forward Loan Fund, Gov. Andrew Cuomo announced Companies with 20 or fewer...

To view the full story, click the title link.

The move could hamstring the Chinese tech giant if it prevents the firm’s customers from getting the latest versions of services such as Maps and Gmail.

Shareholders are voting on whether to push the tech giant to examine the human rights and financial risks of the surveillance technology.

Artificial intelligence may help doctors make more accurate readings of CT scans used to screen for lung cancer.

The great hope for people without a bachelor’s degree hasn’t yet spread beyond small-scale success stories.

When it comes to disinformation, all signs suggest the 2020 presidential campaign will make 2016 look like a mere test run, our columnist writes.

The price was relatively small, but the deal may have a big impact on the race between the United States and China to build more powerful computers.